                         SEQUENCE LISTING

<110>  INSERM
 
<120>  USE OF INHIBITORS OF STRESS GRANULE FORMATION FOR TARGETING THE 
       REGULATION OF IMMUNE RESPONSES

<130>  BIO18309 FOURNIE

<160>  22    

<170>  PatentIn version 3.5

<210>  1
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  EIF4G1-F

<400>  1
atttccggtc tggttggtct g                                                 21


<210>  2
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  EIF4G1-R

<400>  2
ccagcacccc ctcgattaag aa                                                22


<210>  3
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  ELAV1L-F

<400>  3
ggtgacatcg ggagaacgaa                                                   20


<210>  4
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  ELAV1L-R

<400>  4
cccaagctgt gtcctgctac                                                   20


<210>  5
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  TIA1-F

<400>  5
gagtaacctc tggtcagccg                                                   20


<210>  6
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  TIA1-R

<400>  6
ccgacgtata gagtcttggg c                                                 21


<210>  7
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  G3BP1-F

<400>  7
ctcagccgcg taggtttgga                                                   20


<210>  8
<211>  19
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  G3BP1-R

<400>  8
tctcacaaat tcccgcccg                                                    19


<210>  9
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  PDCD1-F

<400>  9
cagttccaaa ccctggtggt                                                   20


<210>  10
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  PDCD1-R

<400>  10
ggctcctatt gtccctcgtg                                                   20


<210>  11
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  CTLA4-F

<400>  11
tggacacggg actctacatc t                                                 21


<210>  12
<211>  19
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  CTLA4-R

<400>  12
ggcacggttc tggatcaat                                                    19


<210>  13
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  TIM3-F

<400>  13
tgtgcctaac agaggtgtcc                                                   20


<210>  14
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  TIM3-R

<400>  14
ttccacttct gaggaccttg t                                                 21


<210>  15
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  LAG3-F

<400>  15
ttggcaatca tcacagtgac tc                                                22


<210>  16
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  LAG3-R

<400>  16
gctccacaca aagcgttctt                                                   20


<210>  17
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  CD69-F

<400>  17
ccaccagtcc ccatttctca a                                                 21


<210>  18
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  CD69-R

<400>  18
gtattggccc actgataagg c                                                 21


<210>  19
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  CD3-F

<400>  19
tgcctcttat cagttggcgt                                                   20


<210>  20
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  CD3-R

<400>  20
ccaggatact gagggcatgt                                                   20


<210>  21
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  GAPDH-F

<400>  21
ctcctgttcg acagtcagcc                                                   20


<210>  22
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  GAPDH-R

<400>  22
ctcctgttcg acagtcagcc                                                   20


